Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.
Michael M WollringJan-Michael WernerElena K BauerCaroline TscherpelGarry S CecconPhilipp LohmannGabriele StoffelsChristoph KabbaschRoland GoldbrunnerGereon R FinkKarl-Josef LangenNorbert GalldiksPublished in: Neuro-oncology (2022)
Data suggest that FET PET provides complementary information to RANO criteria for response evaluation of lomustine-based chemotherapy early after treatment initiation.